A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis
Clinical trial NCT02685904 · TERMINATED
Trial details
- NCT number
- NCT02685904
- Sponsor
- Mycenax Biotech Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-06
- Primary completion
- 2018-01-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.